Hepatoprotective effect of pycnogenol in gentamicin-induced liver injury in rats

Main Article Content

Tuba Ozcan Metin

Abstract

Aim: The present study aimed to investigate the possible hepatoprotective effect pycnogenol (PYC) in gentamicin (GEN)-induced liver injury in rats.


Materials and Methods: The study consisted of four groups of seven rats; control, PYC (20 mg/kg for 8 days), GEN (80 mg/kg for 8 days) and GEN+PYC. At the end of the experiment, liver tissues of all groups were collected for histopathological and immunohistochemical (fibrillin-1, caspase-3, and betatrophin antibodies) evaluation.


Results: Histopathological analysis revealed that the GEN treated group had liver damage as a result of the GEN administration compared to the control group. Additionally, fibrillin-1, caspase-3, and betatrophin expression all increased in rat liver tissues. However, PYC pretreatment significantly reduced the expression of the aforementioned antibodies and mitigated liver damage.


Conclusion: The anti-apoptotic and antioxidant properties of PYC may help to preserve liver histoarchitecture against GEN-induced hepatotoxicity.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ozcan Metin, T. (2023). Hepatoprotective effect of pycnogenol in gentamicin-induced liver injury in rats. Annals of Medical Research, 30(3), 370–374. Retrieved from http://annalsmedres.org/index.php/aomr/article/view/4386
Section
Original Articles